# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Frederick Cook (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EX006-SYN
- Date: 2026-07-21
- Fictional facility: St. Posthumous Health Center
- Fictional author: Harriet Okafor-Brandt, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Two-week follow-up of high blood pressure and a right carotid bruit, with carotid duplex ultrasound and vascular neurology consultation today. **S**

## History of present illness

Mr. Cook returns two weeks after his first visit, on the day of his carotid duplex ultrasound and his consultation with Dr. Abernathy-Mensah. He measured his blood pressure at home twice a day for seven days with the upper-arm cuff from the clinic; the fourteen readings average 154/90. He has had no headache, chest pain, breathlessness, weakness, numbness, speech trouble or loss of vision in either eye. He has cut down on salt and walks each day. He has signed the request for his prison medical records, which have not yet arrived, and has met the social worker once. He feels low at times and ashamed when people recognize his name, but he is sleeping and writing. **S**

| Element | Detail |
|---|---|
| Home blood pressure | Fourteen readings over seven days, average 154/90 |
| Symptoms | None; no stroke or eye symptoms |
| Lifestyle | Less salt; daily walking |
| Records | Prison medical records requested, not yet received |
| Mood | Low at times; ashamed when recognized; sleeping and writing |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Cardiovascular | Negative | No chest pain, palpitations, or ankle swelling |
| Neurological | Negative | No weakness, numbness, speech trouble, or dizziness |
| Eyes | Negative | No transient loss of vision in either eye |
| Psychiatric | Positive | Low at times and ashamed when recognized; no thoughts of self-harm |

4 systems reviewed. **S**

## Current medications

- Hydrochlorothiazide 25 mg tablet, one tablet by mouth each morning **S**
- Amlodipine 5 mg tablet, one tablet by mouth daily **S**
- Atorvastatin 40 mg tablet, one tablet by mouth daily **S**
- Aspirin 81 mg delayed-release tablet, one tablet by mouth daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 158/92 mmHg; pulse 72 bpm; respirations 14/min; temperature 36.5 °C; oxygen saturation 97% on room air; weight 75.8 kg; BMI 24.8 kg/m². All vital signs are synthetic.

No condition-specific results recorded.

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 158/92, pulse 72, weight 75.8 kg |
| Neck | Soft right carotid bruit; no left bruit |
| Eyes | Fundi: mild arteriolar narrowing; no hemorrhages, exudates or papilledema |
| Cardiovascular | Regular rhythm; no murmur; radial, femoral and foot pulses normal and equal |
| Neurological | Alert and fluent; no facial asymmetry, drift, weakness or sensory loss |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Essential hypertension, stage 2** (I10). The raised office readings at intake (166/94) are confirmed by home readings averaging 154/90, so this is stage 2 hypertension. Baseline tests are reassuring: sodium 140 and potassium 4.2 mmol/L, creatinine 0.98 mg/dL (eGFR 86), fasting glucose 94 mg/dL, HbA1c 5.5%, urine albumin-to-creatinine ratio 18 mg/g, TSH 2.1 mIU/L, and an ECG without left ventricular hypertrophy. For stage 2 hypertension the 2025 AHA/ACC guideline recommends starting two first-line drugs of different classes. With carotid atherosclerosis the target is below 130/80. **S**
   - Hydrochlorothiazide 25 mg each morning and amlodipine 5 mg daily.
   - Sodium, potassium and creatinine in about four weeks.
   - Echocardiogram for stage 2 hypertension.
   - Continue home readings three days a week and bring them.
   - Sodium below 2,300 mg a day, ideally nearer 1,500 mg, the DASH eating pattern, and daily walking.
2. **Asymptomatic right internal carotid stenosis, 50 to 69 percent** (I65.21). The right carotid bruit heard at intake now has its explanation. Duplex today shows a 50 to 69 percent stenosis of the right internal carotid artery (peak systolic velocity 165 cm/s, end-diastolic velocity 38 cm/s, ratio 2.6) and less than 50 percent plaque on the left, with no symptoms of stroke or transient ischemic attack. Dr. Abernathy-Mensah recommends best medical therapy rather than endarterectomy or stenting, which are considered for asymptomatic stenosis of 70 percent or more. LDL cholesterol 148 mg/dL. **S**
   - Atorvastatin 40 mg daily, with a lipid panel and ALT in 4 to 12 weeks.
   - Aspirin 81 mg daily.
   - Blood pressure below 130/80.
   - Learn the BE FAST warning signs and call 911 at once for any of them.
   - Repeat duplex in twelve months, or sooner for symptoms.
3. **Re-entry after incarceration** (Z65.2). PHQ-9 7 at intake, mild, with no thoughts of self-harm; shame about his conviction and his past is a recurring theme. Prison records not yet received. **S**
   - Continue with the social worker on housing, Social Security and Medicare.
   - A low-cost pharmacy plan for the new medicines.
   - Review mood at each visit.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Office blood pressure, seated, average of two readings | Every visit | Completed today | 158/92 mmHg |
| Self-management | Home blood pressure monitoring | At diagnosis and after each treatment change | Completed today | Average 154/90 over seven days; confirms hypertension |
| Laboratory | Sodium, potassium, creatinine and eGFR | Baseline; early after starting a diuretic or an ARB; then every 6 months | Up to date | Baseline at intake: sodium 140, potassium 4.2 mmol/L, creatinine 0.98 mg/dL, eGFR 86; repeat ordered for about four weeks after starting hydrochlorothiazide |
| Laboratory | Lipid panel | Baseline; 4 to 12 weeks after starting a statin; then every 3 to 12 months | Up to date | Baseline at intake: total cholesterol 228, HDL 46, LDL 148, triglycerides 170 mg/dL; repeat ordered for 4 to 12 weeks after starting atorvastatin |
| Laboratory | ALT on a statin | Baseline, then with the first lipid check or with symptoms | Up to date | Baseline at intake 22 U/L |
| Laboratory | HbA1c or fasting glucose | Annually | Up to date | HbA1c 5.5% and fasting glucose 94 mg/dL at intake |
| Laboratory | Urine albumin-to-creatinine ratio | Annually | Up to date | 18 mg/g at intake |
| Laboratory | TSH | At diagnosis | Up to date | 2.1 mIU/L at intake |
| Imaging | 12-lead ECG | At diagnosis | Up to date | At intake: sinus rhythm, no left ventricular hypertrophy |
| Imaging | Echocardiogram | At diagnosis of stage 2 hypertension | Ordered | Ordered today for stage 2 hypertension |
| Examination | Fundoscopic examination | Annually | Completed today | Mild arteriolar narrowing; no hemorrhages or papilledema |
| Examination | Peripheral pulses and ankle-brachial index | Every 2 to 3 years at 65 or older | Completed today | Pulses normal and equal; no claudication. Ankle-brachial index due at the annual wellness visit |
| Imaging | Carotid duplex ultrasound for known 50 percent or greater stenosis on medical therapy | At diagnosis, then yearly | Completed today | Right internal carotid 50 to 69 percent, left below 50 percent |
| Referral | Vascular neurology consultation | Once, at diagnosis | Completed today | Seen by Dr. Abernathy-Mensah today |
| Medication safety | Antiplatelet adherence and bleeding | Every visit | Completed today | Aspirin starts today; no history of ulcer or bleeding; avoid NSAIDs |
| Medication safety | Statin adherence and muscle symptoms | Every visit | Completed today | Atorvastatin starts today; report muscle pain |
| Self-management | Stroke warning signs (BE FAST) and calling 911 | At diagnosis, then every visit | Completed today | Taught; he repeated the signs back |
| Survey | Depression screen (PHQ-9) | Annually | Up to date | PHQ-9 7 at intake; mood reviewed today |
| Self-management | Re-entry social needs: housing, income, benefits, records | Every visit until settled | Completed today | Room by the week; benefits applications started; records requested |

## Goal progress

- Office and home blood pressure below 130/80 mmHg by four months. In progress; target 2026-10-27. **S**
- LDL cholesterol lowered by at least half on a statin. In progress; target 2026-09-29. **S**
- Knows the warning signs of stroke and to call 911 at once. Outcome by 2026-07-21: Taught and repeated back the BE FAST signs at the consultation visit. **S**
- A stable room, Social Security and Medicare in place, and a health insurance card in hand. In progress; target 2026-09-29. **S**

## Medication changes

- Started: Hydrochlorothiazide 25 mg tablet, one tablet by mouth each morning **S**
- Started: Amlodipine 5 mg tablet, one tablet by mouth daily **S**
- Started: Atorvastatin 40 mg tablet, one tablet by mouth daily **S**
- Started: Aspirin 81 mg delayed-release tablet, one tablet by mouth daily **S**

## Guideline basis

- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (Jones DW, et al. Hypertension 2025;82:e212-e316) (2025), American Heart Association; American College of Cardiology
- CMID: Clinical Monitoring Intelligence Database, hypertension, hyperlipidemia and stroke/TIA monographs (2026), Aether Forge
- 2024 Guideline for the Primary Prevention of Stroke: A Guideline From the American Heart Association/American Stroke Association (Bushnell C, et al. Stroke 2024;55:e344-e424) (2024), American Heart Association/American Stroke Association
- Society for Vascular Surgery clinical practice guidelines for management of extracranial cerebrovascular disease (AbuRahma AF, et al. J Vasc Surg 2022;75(1S):4S-22S) (2021), Society for Vascular Surgery
- European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease (Naylor R, et al. Eur J Vasc Endovasc Surg 2023;65:7-111) (2023), European Society for Vascular Surgery
- 2018 AHA/ACC Guideline on the Management of Blood Cholesterol (Grundy SM, et al. Circulation 2019;139:e1082-e1143) (2018), American Heart Association; American College of Cardiology

## Follow-up

- Preventive examination in two weeks. Hypertension review in four weeks, with electrolytes and creatinine and the echocardiogram. **S**
- Next scheduled visit 2026-08-04: initial preventive physical examination (Welcome to Medicare). **S**
